Bayer to support 11 digital health startups, 5 of which are developing behavioral/ cognitive/ mental health solutions
_______________
Bayer inks deals with eleven startups under G4A Digital Health Partnerships program (press release):
“Bayer announced today that the company has signed collaboration agreements with eleven digital health startups. As part of the program, Bayer will support these startup companies aiming for longer-term collaborations to drive forward the development of specific digital solutions to improve patients’ health in the fields of cardiovascular diseases, oncology, ophthalmology, pulmonology, radiology as well as digital therapeutics.”
Out of the eleven digital health startups, five are developing solutions directly relevant to behavioral/ cognitive/ mental health:
- NeuroTracker (Canada): Cognitive training program designed to improve cognitive and mental performance.
- Wellthy Theapeutics (India): Wellthy Therapeutics has a clinically validated behavioral intervention platform to help people change their behaviors and reduce their risk of chronic disease.
- Litesprite (USA): Litesprite creates games that combine medical treatment and engagement of mobile gaming to help patients proactively manage chronic health conditions such as stress, anxiety and depression.
- Upside Health (USA): Upside Health has developed Ouchie, an app for chronic pain management through tools such as cognitive behavioral therapy, community support, pain tracking, education resources and integration with clinicians.
- OKKO Health (United Kingdom): OKKO Health has developed a personalized smartphone software for accurate remote monitoring of visual health outside of ophthalmology clinics.
News in Context:
- The National Health Service (NHS) in the UK considers adding a 5‑minute cognitive test to its annual health check-up
- CVS Health: Cognitive behavioral therapy (CBT) apps may help you more than sleeping pills
- Startup Aural Analytics raises $4.3M to monitor neurological health by analyzing speech patterns
- The FDA creates new Digital Health unit to reimagine regulatory paths in the age of scalable, AI-enhanced innovation
- Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright
- Mindstrong Health identifies digital biomarkers of cognitive function using smartphone data